#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Granulomatosis with polyangiitis Focal segmental glomerulosclerosis Intracranial calcification Liver abscess Oesophageal carcinoma Metachromatic leukodystrophy Canavan disease Neuroendocrine carcinoma Myotonic dystrophy Chondrosarcoma Metastases to peritoneum Indolent systemic mastocytosis Anti-myelin-associated glycoprotein antibodies positive HER2 mutant non-small cell lung cancer Muscular dystrophy More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma KBG syndrome – Trials in Disease Amyotrophic lateral sclerosis – Trials in Disease Gaucher’s disease type III – Diagnostics MELAS syndrome – Basic Information Lysosomal storage disorder – Treatment Pituitary-dependent Cushing’s syndrome Noonan syndrome – Treatment Hereditary optic atrophy – Life with Disease Propionic acidaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rifapentine Human Coagulation Factor Ii Cefotaxime Sodium Lisdexamfetamine Dimesylate Elebsiran Levobupivacaine Resomelagon Garetosmab Ecoo1A Vimseltinib Ro7269162 Clemizole Hydrochloride Allo-501A Edoxaban Ptc518 Cefazolin Carbamazepine Gen1047 Fostemsavir Bgb-15025 Citrate More therapies…

    Learn about Your Condition

    Pemphigus Chondrocalcinosis Cytomegalovirus infection Cerebral palsy Atrial flutter Colorectal cancer stage III Fatty acid oxidation disorder Lymphocytic leukaemia Non-small cell lung cancer Adenocarcinoma of colon Procedural headache Breast cancer metastatic Cholestatic pruritus Radicular pain T-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Axon Clinical s.r.o.

Axon Clinical s.r.o.

Ostrovskeho 253/3, Smichov, Prague, 150 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    4 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium Bulgaria Czechia France Germany Hungary +7

  • Study on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Czechia France Germany Poland Spain

  • Study on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Czechia Germany Italy Poland Spain

  • Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 2 Encoding Soluble Cd59
    • Triamcinolone Acetonide
    • Prednisone
    Belgium Czechia Denmark Germany Hungary Italy +5

  • Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Retinal vein occlusion
    Investigated Drugs:
    • Fluorescein Sodium
    • Aflibercept
    Austria Bulgaria Czechia Estonia France Germany +8

  • Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Avacincaptad Pegol
    • Fluorescein Sodium
    Austria Belgium Croatia Czechia France Germany +4

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    • Macular oedema
    Investigated Drugs:
    • Eye103
    • Fluorescein Sodium
    • Ranibizumab
    Austria Croatia Czechia France Germany Hungary +6
Previous Page
1 … 3 4 5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!